U.S. Healthtech Stock News

If you are looking at Akamai Technologies and wondering whether the current share price still makes sense, this article will walk through what the numbers say about value and risk. The stock last closed at US$100.13, with returns of 5.3% over 30 days, 17.7% year to date and 28.3% over the past year, although the most recent 7 days showed a 7.6% decline. Recent news flow around Akamai has focused on its role in content delivery, cloud security and edge computing. This helps explain why the...

ACV Auctions (ACVA) has wrapped up FY 2025 with Q4 revenue of US$183.6 million and a basic EPS loss of US$0.11, while trailing twelve month revenue came in at US$759.6 million with a basic EPS loss of US$0.39. The company has seen revenue move from US$159.5 million in Q4 2024 to US$183.6 million in Q4 2025, with quarterly EPS losses ranging between US$0.04 and US$0.16 over the past six reported quarters. This sets the stage for investors to focus on how quickly those losses might narrow...

If you are wondering whether Gartner's current share price still reflects its underlying worth, you are not alone. The stock's recent performance has many investors rechecking the numbers. Over the past week the share price returned negative 5.7%, over 30 days it returned negative 36.4%, and year to date it is down 37.8%, while the 1 year return sits at negative 70.7% and the 5 year return at negative 19.6%. These moves come as investors reassess valuations across the US software sector and...

Novanta (NOVT) has wrapped up FY 2025 with fourth quarter revenue of US$258.3 million and basic EPS of US$0.46, alongside net income of US$17.5 million, setting the tone for how investors will read its latest earnings update. The company has seen quarterly revenue move from US$238.1 million and EPS of US$0.46 in Q4 2024 to US$258.3 million and EPS of US$0.46 in Q4 2025. Trailing twelve month net income of US$53.8 million on revenue of US$980.6 million provides the broader backdrop. With net...

Tutor Perini (NYSE:TPC) reports strong operational recovery with better cash flow and margin performance. The company posts a sharp improvement in quarterly EPS growth alongside healthier free cash flow. These operational shifts point to a business that is running more efficiently and generating stronger results from existing projects. Tutor Perini’s recent progress comes with the stock trading at $85.87, after a 4.4% gain over the past week and 13.0% over the past month. The move adds to a...

If you are wondering whether KLA’s current share price still makes sense after a huge run, this article is going to focus squarely on what the numbers say about value. The stock last closed at US$1,506.65, with returns of 2.5% over 7 days, slightly negative 0.4% over 30 days, 18.2% year to date and 109.4% over the past year, along with a very large 3 year and 5 year return of 308.2% and 412.5% respectively. Recent market attention on KLA has centered on its role as a key supplier in the...

EverQuote (EVER) just wrapped up FY 2025 with fourth quarter revenue of US$195.3 million and basic EPS of US$1.60, alongside net income of US$57.8 million, setting a clear headline for its latest results. The company has seen revenue move from US$147.5 million and EPS of US$0.35 in Q4 2024 to US$195.3 million and EPS of US$1.60 in Q4 2025, with trailing twelve month revenue at US$692.5 million and EPS at US$2.75 giving investors a fuller view of the earnings run rate. Taken together with a...

Bowhead Specialty Holdings (BOW) just wrapped up FY 2025 with Q4 total revenue of US$151.7 million and basic EPS of US$0.40, alongside trailing 12 month revenue of US$551.6 million and EPS of US$1.59 that sit against a one year earnings increase of 40.6%. Over recent quarters the company has seen revenue move from US$119.3 million in Q4 2024 to US$151.7 million in Q4 2025, while basic EPS shifted from US$0.42 to US$0.40. This sets up a picture where margins and profit efficiency are firmly in...

UFP Industries (UFPI) has wrapped up FY 2025 with fourth quarter revenue of US$1.3 billion and EPS of US$0.70, while trailing 12 month figures show revenue of US$6.3 billion and EPS of US$5.00, giving investors a clear read on both the quarter and the year as a whole. Over recent quarters the company has seen revenue move from US$1.6 billion in Q1 2025 to US$1.8 billion in Q2 2025 and US$1.6 billion in Q3 2025 before landing at US$1.3 billion in Q4. EPS shifted from US$1.30 to US$1.70,...

Earlier in February 2026, Emerson Electric entered into a new US$2.00 billion 364-day credit facility to backstop commercial paper and general corporate needs, while also reporting quarterly results that matched revenue expectations but fell short on EBITDA and near-term EPS guidance. Despite maintaining substantial unused liquidity and renewing short-term credit lines, Emerson’s weaker profitability metrics versus peers have raised questions about the strength of its execution and near-term...

Avidity Biosciences (RNA) has wrapped up FY 2025 with fourth quarter revenue of about US$0.9 million, a basic EPS loss of US$1.54 and a net loss of roughly US$237.1 million. Over recent quarters the company has seen revenue move from US$2.3 million in Q3 2024 to US$12.5 million in Q3 2025. Basic EPS shifted from a loss of US$0.65 in Q3 2024 to a loss of US$1.27 in Q3 2025, and trailing 12 month EPS landed at a loss of US$4.97. This sets the stage for a results season where investors are...

Why Vir Biotechnology is back on investor radars Vir Biotechnology (VIR) has caught investor attention after a strong share price move over the past month, prompting fresh interest in how its infectious disease pipeline and financial profile stack up today. See our latest analysis for Vir Biotechnology. The latest move sits on top of a 59.76% year to date share price return and a 48.51% 90 day share price return. However, the 3 year total shareholder return of negative 58.38% highlights how...

In February 2026, Cardinal Health’s board approved a quarterly dividend of US$0.5107 per share, payable on April 15, 2026 to shareholders of record on April 1, 2026, while the company also reported stronger-than-expected quarterly results and raised its fiscal 2026 profit outlook. At the same time, Cardinal Health highlighted growing momentum in higher-margin specialty and at-home healthcare businesses and released its 2026 Biosimilars Report, underscoring the expanding role of biosimilars...

WeRide (NasdaqGM:WRD) and Uber launched a commercial Robotaxi service in downtown Abu Dhabi, covering core city areas. The service marks the first commercial Robotaxi operation in Abu Dhabi's city center. The partners outlined plans to deploy at least 1,200 Robotaxis across the Middle East by 2027. For you as an investor, this move puts WeRide directly into the conversation around autonomous ride hailing in a high profile Middle Eastern market. The company is bringing its autonomous driving...

Brighthouse Financial (BHF) closed out FY 2025 with Q4 revenue of US$1,689 million and basic EPS of US$1.94, alongside net income of US$112 million, setting a clear marker for how the year finished. Over recent quarters, the company has seen revenue move from US$2,373 million in Q1 2025 to US$860 million in Q2, US$1,808 million in Q3 and then US$1,689 million in Q4. Basic EPS swung from a loss of US$5.05 in Q1 to US$1.04 in Q2, US$7.92 in Q3 and US$1.94 in Q4, giving investors plenty to weigh...

If you are wondering whether Alliant Energy at around US$71.63 is still reasonably priced or already rich, you are not alone. That is exactly what this article aims to unpack. The stock shows returns of 0.7% over 7 days, 7.2% over 30 days, 9.2% year to date, 16.0% over 1 year, 54.8% over 3 years and 78.8% over 5 years, which naturally raises questions about how much of this is already reflected in the current share price. Recent attention on utilities companies and interest rate expectations...

Kiniksa Pharmaceuticals International (KNSA) is back in focus after reporting Q4 2025 results, with revenue of US$202.13 million and net income of US$14.2 million, compared with a net loss a year earlier. See our latest analysis for Kiniksa Pharmaceuticals International. Despite the latest earnings, the recent 1-day share price return of an 8.21% decline and 7-day share price return of a 4.14% decline show some cooling in the very strong trend reflected in the 1-year total shareholder return...

If you are wondering whether RBC Bearings is still fairly priced after a strong run, this breakdown will help you weigh what you are paying against what you are actually getting. The share price closed at US$571.57, with returns of 3.4% over 7 days, 13.4% over 30 days, 24.6% year to date, 59.9% over 1 year, 148.7% over 3 years and 189.6% over 5 years. This naturally raises questions about value and risk. Recent coverage has focused on how investors are reassessing companies in industrial and...

Latest FY 2025 Earnings Snapshot Diamondback Energy (FANG) has just closed out FY 2025 with Q4 revenue of US$3.8 billion and a basic EPS loss of US$5.08, compared with Q4 FY 2024 revenue of US$3.5 billion and basic EPS of US$3.67. Over the same period, trailing twelve month revenue moved from US$10.6 billion at the end of FY 2024 to US$14.9 billion at the end of FY 2025, while trailing EPS shifted from US$15.53 to US$5.73. With trailing net margin down from 31.4% to 11.1% and profits under...

Henry Schein (HSIC) has wrapped up FY 2025 with fourth quarter revenue of US$3.4 billion and basic EPS of US$0.86, alongside trailing twelve month revenue of US$13.2 billion and EPS of US$3.29 that frame the latest print in a broader context. The company has seen quarterly revenue move from US$3.2 billion in Q4 2024 to US$3.4 billion in Q4 2025, with basic EPS shifting from US$0.75 to US$0.86 over the same period. Trailing twelve month EPS moved from US$3.08 to US$3.29 as investors weigh...

Genworth Financial (GNW) has wrapped up FY 2025 with Q4 revenue of US$1.8 billion and a basic EPS loss of US$0.05 from continuing operations, while trailing twelve month revenue sits at US$7.3 billion and EPS at US$0.54. Over recent periods the company has seen quarterly revenue move in a tight band between US$1.8 billion and US$1.9 billion, with basic EPS ranging from a loss of roughly US$0.05 in Q4 2025 to a profit of about US$0.30 in Q3 2025. This pattern is prompting investors to focus on...

Event context and recent share performance Tetra Tech (TTEK) has recently drawn investor attention after a period of weaker share performance, with the stock down about 2% over the past day, 7% over the past week, and 11% over the past month. Over the past 3 months, the share price shows a decline of about 5%, while longer term total returns sit near 10% over the past year and around 27% over the past 5 years. See our latest analysis for Tetra Tech. The recent share price pullback, including...

Lockheed Martin (NYSE:LMT) has secured major contracts to expand production capacity for THAAD and PAC-3 missile interceptors for the U.S. Department of Defense. The new missile interceptor agreement includes a profit-sharing structure tied to the expanded production program. The company also signed a contract to supply advanced C-130J training devices to the Royal Australian Air Force. For investors watching NYSE:LMT, these contracts come with the stock trading at $664.43, with returns of...

Intapp (INTA) is back in focus after unveiling a series of AI focused partnerships, including tighter integration with Anthropic's Claude and Harvey, and new due diligence connectivity with ToltIQ for DealCloud users. See our latest analysis for Intapp. Despite this run of AI focused partnerships, Intapp's recent share price return has been weak, with a 30 day share price return of 44.85% and a year to date share price return of 51.40%, while the 1 year total shareholder return of 67.35% and...